The examples in this article are illustrative, not treatment plans
Tuesdays announcement by the Institute for Clinical and Economic Review (ICER) that weight-loss drugs from Novo Nordisk and Eli Lilly are now cost-effective is an important victory for the two pharmaceutical companies, being that the assessment could pave the way for growth in US companies health insurance plans for their employees, according to a statement from Bank of America, whose analyst Tim Anderson follows Novo Nordisks US competitor, Eli Lilly.
Because theyre considered natural nutritional boosters as opposed to actual drugs, brands (and people) can claim a lot about them without having much evidence to back it up
Docusate sodium | Drugs BNF NICE
If cost is your primary concern, working with a licensed telehealth provider can offer transparent pricing and medically supervised treatment plans
Working with your provider to find the right treatments and identify your triggers is essential